Exponent, Inc. (NASDAQ:EXPO - Get Free Report) shares hit a new 52-week low on Tuesday . The stock traded as low as $72.30 and last traded at $72.34, with a volume of 245513 shares traded. The stock had previously closed at $74.46.
Exponent Trading Down 1.8%
The firm's 50-day moving average price is $76.34 and its two-hundred day moving average price is $81.68. The stock has a market cap of $3.69 billion, a PE ratio of 35.46 and a beta of 0.90.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The firm had revenue of $137.44 million during the quarter, compared to analysts' expectations of $134.63 million. During the same quarter in the prior year, the company earned $0.59 EPS. The company's revenue was up .2% compared to the same quarter last year. On average, analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were given a $0.30 dividend. The ex-dividend date was Friday, June 6th. This represents a $1.20 annualized dividend and a dividend yield of 1.65%. Exponent's payout ratio is presently 58.54%.
Insider Activity at Exponent
In related news, VP Joseph Rakow sold 1,573 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Bradley A. James sold 2,694 shares of the firm's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total transaction of $214,226.88. The disclosure for this sale can be found here. Insiders sold 6,267 shares of company stock valued at $489,120 over the last 90 days. Insiders own 1.60% of the company's stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. PineStone Asset Management Inc. raised its holdings in shares of Exponent by 6.6% in the second quarter. PineStone Asset Management Inc. now owns 122,694 shares of the business services provider's stock worth $9,166,000 after buying an additional 7,600 shares during the last quarter. Mitchell & Pahl Private Wealth LLC raised its holdings in shares of Exponent by 14.3% in the second quarter. Mitchell & Pahl Private Wealth LLC now owns 7,666 shares of the business services provider's stock worth $573,000 after buying an additional 957 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Exponent in the second quarter worth $9,993,000. Gallacher Capital Management LLC acquired a new stake in shares of Exponent in the second quarter worth $654,000. Finally, Strs Ohio acquired a new stake in shares of Exponent in the first quarter worth $316,000. Hedge funds and other institutional investors own 92.37% of the company's stock.
Exponent Company Profile
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.